Several studies have demonstrated that patients with SLE have elevated circulating IFNs [21–23], whose signaling contributes to the steady-state expression of MLKL and the initiation of necroptosis, which not only causes tissue damage [6], but may also form a dynamic feedback loop in SLE pathogenesis. This evidence concerns the gene MLKL and systemic lupus erythematosus.